Insights on the Ophthalmology Devices Global Market to 2027 – Untapped Potential in Emerging Economies and Technological Advancements in Ophthalmic Devices Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ophthalmology Devices Market Research Report by Devices (Diagnosis Devices, Surgical Devices, and Vision Care), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmology Devices Market size was estimated at USD 59.85 billion … [Read more…]

Adrestia appoints Will Lewis as Chair, establishes US Operations and appoints new functional leads

Will brings a strong track record of creating value through company-building, deep relationships with capital markets and rare disease drug development and commercialization experience Other appointments include VP of Business Development and VP of U.S. Operations to oversee global clinical and regulatory operations Company advancing several synthetic rescue-based programs for intractable genetic diseases, both in-house … [Read more…]

Rite Aid Corporation Reports Fiscal 2023 Second Quarter Results

Retail Comparable Store Prescriptions Increased 3.1 Percent – Comparable Store Acute Prescriptions, Excluding COVID Immunizations, Increased 5.3 Percent Revenues of $5.9 billion, Compared to Prior Year Revenues of $6.1 billion Net Loss per Share of $6.07, Compared to the Prior Year Net Loss per Share of $1.86 Driven by Non-Cash Goodwill Impairment Charge Adjusted Net … [Read more…]

Enanta Pharmaceuticals Presents Preclinical Data for its Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Programs at the 12th International RSV Symposium

EDP-323 Demonstrates Potent Inhibition of RSV Replication and Associated Pathology 3D Airway Model Provides Accurate Insight into the Dynamics of RSV Infection Advances in hMPV Virology Methods Improve In Vitro Characterization of Direct-Acting Antivirals WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and … [Read more…]

pliability Adds Professional Golfer Lee Westwood to Athlete Roster

Mobility and recovery app pliability announces its newest athlete signing, professional golfer Lee Westwood NEW YORK–(BUSINESS WIRE)–Today, mobility and recovery app pliability, who recently rebranded from ROMWOD, announces professional golfer Lee Westwood as the newest addition to its athlete roster. This partnership marks the next stage of pliability’s evolution to educate and demonstrate that movement … [Read more…]

Spectrum Chemical Signs U.S. Distribution Agreement with DFE Pharma to Provide BioHale® Brand Products for Biopharmaceutical Manufacturing

Through the agreement Spectrum’s robust portfolio is leveraged to deliver more than 90 percent of upstream and downstream bioprocessing required raw materials. GARDENA, Calif.–(BUSINESS WIRE)–#BiotechWeekBoston—Spectrum Chemical Mfg. Corp., a leading global provider of specialty, fine and cGMP chemicals, as well as laboratory equipment and supplies, has entered into a new U.S. distribution agreement with DFE … [Read more…]

Entos Pharmaceuticals Passes Significant Enrollment Milestone in Phase 2 Clinical Trial of its COVID-19 DNA Vaccine

This phase 2 trial evaluates the safety, tolerability, and immunogenicity of Covigenix VAX-001-1b in healthy adults 18 years and older A total of 268 participants have been enrolled in the study at two sites in Burkina Faso, completing the single and two-dose cohorts EDMONTON, Alberta & OUAGADOUGOU, Burkina Faso–(BUSINESS WIRE)–Entos Pharmaceuticals (Entos), a clinical-stage biotechnology … [Read more…]

Axcella Announces Positive Interim Data from Phase 2b EMMPACT Study of AXA1125 in Nonalcoholic Steatohepatitis (NASH)

Subjects enrolled with biopsy confirmed NASH experienced clinically and statistically significant improvements in liver stiffness as measured by FibroScan, a non-invasive measure of liver fibrosis Subjects with NASH experienced clinically and statistically significant improvements in alanine aminotransferase (ALT), a measure of liver cell inflammation, at both dose levels of AXA1125 Findings demonstrate improvement in hepatic … [Read more…]

Lionrock Adds Ketamine Assisted Psychotherapy Program to State-of-the-Art Treatment Offerings for Substance Use Disorder

Research Shows Ketamine in Conjunction with Psychotherapy Could Help Combat National Substance Abuse Crisis REDWOOD CITY, Calif.–(BUSINESS WIRE)–Lionrock, the inventor of telehealth services for substance use disorders (SUDs) treatment and recovery services in the United States, today announces its Ketamine Assisted Psychotherapy (KAP) pilot program, the latest treatment method to be added to the company’s … [Read more…]